Acadian Asset Management LLC Passage Bio, Inc. Transaction History
Acadian Asset Management LLC
- $28.7 Billion
- Q1 2024
A detailed history of Acadian Asset Management LLC transactions in Passage Bio, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 961,271 shares of PASG stock, worth $759,404. This represents 0.0% of its overall portfolio holdings.
Number of Shares
961,271
Previous 604,678
58.97%
Holding current value
$759,404
Previous $610,000
112.46%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding PASG
# of Institutions
52Shares Held
33MCall Options Held
20.3KPut Options Held
500-
Orbimed Advisors LLC San Diego, CA10.1MShares$8 Million0.31% of portfolio
-
Versant Venture Management, LLC San Francisco, CA4.96MShares$3.92 Million9.33% of portfolio
-
Vestal Point Capital, LP New York, NY4.5MShares$3.56 Million0.5% of portfolio
-
New Leaf Venture Partners, L.L.C. New York, NY2.5MShares$1.97 Million2.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.07MShares$1.64 Million0.0% of portfolio
About Passage BIO, Inc.
- Ticker PASG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,463,200
- Market Cap $43M
- Description
- Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...